Home
Search
BIO International Convention   |   June 3-6, 2024

Speakers & Presenters

All Speakers
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
By Count|Alphabetical
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Results
Julie Eastland
CEO, HARPOON THERAPEUTICS
Beyond Equity: Extreme Innovation in Financing for Public Biotechs
Jens Eckstein
MANAGING PARTNER, APOLLO HEALTH VENTURES
Healthy Returns: Healthspan Investment Comes of Age
Celia Economides
EXECUTIVE VICE PRESIDENT AND CHIEF FINANCIAL OFFICER, GRITSTONE BIO
Should I stay (Private) or should I go (Public)?
Danielle Economo
SENIOR DIRECTOR, SCIENCE AND REGULATORY AFFAIRS, JOHNSON & JOHNSON
FDA Sponsor Interaction: Best Practices and New PDUFA Formal Meetings
Advancing Digital Health Innovation in the Gray Space of Evolving FDA Regulations: What to Expect in 2023 and Beyond
Re-Imagining Drug Development and Regulatory Submissions through Cloud-Based Technologies
Washington, United States
Anne-Virginie Eggimann
CHIEF REGULATORY OFFICER, TESSERA THERAPUETICS
Women at the Crossroads in Gene Editing
Falk Ehmann, MD, PhD
CHAIR INNOVATION TASK FORCE, EUROPEAN MEDICINES AGENCY (EMA)
The Healthcare System of the Future: Emerging Technologies that Enable Drug Development and Patient Treatment
Placeholder Photo
Nevan Elam
CEO, REZOLUTE BIO
Raising Capital in Tough Markets
Fiona Elwood, PhD
VP, DISEASE AREA STRONGHOLD LEAD, NEURODEGENERATION, JANSSEN
Treating Neurodegeneration by Targeting the Mechanisms of Aging
Boston, Massachusetts, United States
Mark Emalfarb, BA
CHIEF EXECUTIVE OFFICER, DYADIC INTERNATIONAL, INC
Dyadic International, Inc.
Jupiter, Florida, United States
Yusuf Erkul, MD
CO-FOUNDER & CEO, KERNAL BIOLOGICS, INC.
Kernal Bio
Cambridge, Massachusetts, United States